Finance

Lists
019170:KRX
Shinpoong Pharmaceutical Co Ltd
9 540,00 KRW
-0,62%
(-60,00) 1D
19 ოქტ, 15:30:26 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 019170...
Open
9 200 KRW
High
9 550 KRW
Low
9 180 KRW
Mkt. cap
528,35 მლრ.
Avg. vol.
479,47 ათ.
Volume
139,28 ათ.
52-wk high
15 900 KRW
52-wk low
6 310 KRW
EPS
-20 KRW
Shares outstanding
52,42 მლნ.
No. of employees
656
Open
9 200 KRW
High
9 550 KRW
Low
9 180 KRW
Mkt. cap
528,35 მლრ.
Avg. vol.
479,47 ათ.
Volume
139,28 ათ.
52-wk high
15 900 KRW
52-wk low
6 310 KRW
EPS
-20 KRW
Shares outstanding
52,42 მლნ.
No. of employees
656
News stories
From web sources and news partners
Macau Business
Macau Business
·
52 წუთის წინ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
Meta (META) Faces Fresh Privacy Scrutiny Over AI Smart Glasses
Bloomberg.com
Bloomberg.com
·
10 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
Yahoo Finance
·
23 საათის წინ
Michael Burry Warns of a Stock Market ‘Supervolcano’
About Shinpoong Pharmaceutical Co Ltd
CEOიუ ჯეი-მან
Employees656
Founded1962
Headquarters-
SectorPharmaceutical industry
Websiteshinpoong.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
62,61 მლრდ.
58,04 მლრდ.
54,53 მლრდ.
63,89 მლრდ.
Cost of goods sold
33,91 მლრდ.
33,04 მლრდ.
33,12 მლრდ.
36,90 მლრდ.
Cost of revenue
33,91 მლრდ.
33,04 მლრდ.
33,12 მლრდ.
36,90 მლრდ.
Research and development expenses
2,39 მლრდ.
1,77 მლრდ.
4,19 მლრდ.
2,89 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,41 მლრდ.
19,16 მლრდ.
18,01 მლრდ.
30,48 მლრდ.
Operating expense
21,48 მლრდ.
21,14 მლრდ.
21,77 მლრდ.
35,02 მლრდ.
Total operating expenses
55,39 მლრდ.
54,17 მლრდ.
54,89 მლრდ.
71,92 მლრდ.
Operating income
7,22 მლრდ.
3,87 მლრდ.
-363,22 მლნ.
-8,03 მლრდ.
Other non operating income
37,58 მლნ.
56,74 მლნ.
-42,52 მლნ.
32,83 მლნ.
EBT including unusual items
7,26 მლრდ.
302,61 მლნ.
439,87 მლნ.
-8,00 მლრდ.
EBT excluding unusual items
7,26 მლრდ.
3,25 მლრდ.
423,63 მლნ.
-8,01 მლრდ.
Income tax expense
847,52 მლნ.
-147,88 მლნ.
70,67 მლნ.
-18,14 მლნ.
Effective tax rate
11,67%
-48,87%
16,07%
0,23%
Other operating expenses
43,68 მლნ.
-434,64 მლნ.
105,86 მლნ.
379,89 მლნ.
Net income
6,38 მლრდ.
461,37 მლნ.
358,51 მლნ.
-8,01 მლრდ.
Net profit margin
10,19%
0,79%
0,66%
-12,54%
Earnings per share
-
-
-
-
Interest and investment income
208,75 მლნ.
200,34 მლნ.
246,20 მლნ.
432,18 მლნ.
Interest expense
-642,57 მლნ.
-671,63 მლნ.
-862,72 მლნ.
-856,95 მლნ.
Net interest expenses
-433,82 მლნ.
-471,28 მლნ.
-616,52 მლნ.
-424,77 მლნ.
Depreciation and amortization charges
528,97 მლნ.
372,83 მლნ.
362,48 მლნ.
332,80 მლნ.
EBITDA
10,17 მლრდ.
6,67 მლრდ.
2,42 მლრდ.
-5,26 მლრდ.
Gain or loss from assets sale
-19,00 ათ.
-1,82 მლნ.
-12,35 მლნ.
-6,89 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები